Search

everythinglearnresearchcommunity

for

Search:↓

Proteins like aPKC and PDGF-AA, substances like adenosine and ATP, and adipose-derived stem cells all play important roles in hair growth and health, and could potentially be used to treat hair loss and skin conditions.

Some drugs used to treat immune conditions may cause different types of hair loss.

Targeting NCoR1 can help treat heart enlargement and dysfunction.

Activating TRPV3 reduces skin oil production and increases inflammation, potentially causing dry skin issues.

Ritlecitinib is cost-effective for severe alopecia areata in Japan.

Low-level laser therapy reduces orthodontic relapse in rats, but fulvic acids do not.

Targeting the RAAS with small molecules can improve cardiovascular disease treatments.

New indole-based compounds, particularly cemtirestat, show promise as dual-function drugs for diabetic complications.

Cepharanthine and berbamine may affect SK channels, influencing their therapeutic effects.

Topical PROTACs show promise for treating skin conditions but need better stability and delivery methods.

AR-27 E-Chol siRNA can effectively promote hair regrowth for androgenetic alopecia.

17β-estradiol can reduce inflammation in the skin.

Tofacitinib may help treat Lichen Planopilaris, but more research is needed.

Acid can block TRPV3 from outside the cell but boost its function from inside.

TIP39 and PTH2R help control calcium levels and skin cell development.

Nitroxide drugs can safely and effectively treat age-related diseases like macular degeneration and cardiovascular issues.

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

Previous alopecia areata treatments do not affect the long-term effectiveness of ritlecitinib.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

lncRNA2919 slows down rabbit hair growth by stopping cell growth and causing cell death.

A specific RNA, circNlgn, contributes to heart damage and scarring caused by the cancer drug doxorubicin.

The study concluded that specific proteins are necessary to maintain the structure that holds epithelial cells tightly together.

Longer TA repeats in the SRD5A2 gene may increase acne risk in Chinese people.

Selective androgen receptor modulators (SARMs) are a promising type of drug for various health conditions due to their targeted actions.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

Melatonin may treat rosacea and Alzheimer's by reducing inflammation and affecting blood vessel growth.

GLP-1 receptor agonists may increase the risk of a specific type of hair loss called androgenetic alopecia.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.

Janus kinase inhibitors may help treat lichen planopilaris.

DRDE-07 shows promise for treating skin diseases due to its favorable properties.